Cancer Prevention & Research Institute of Texas (CPRIT)
David Sans serves as an advisor for CPRIT, a state agency that funds cancer research in Texas. Researchers and organizations in Texas are invited to apply for grants that match CPRIT's mission.
CPRIT’s goals are to 1) create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer; 2) attract, create, or expand research capabilities of public or private institutions of higher education and other public or private entities that will promote a substantial increase in cancer research and in the creation of high-quality new jobs in this state; and 3) develop and implement the Texas Cancer Plan.
Anixa Biosciences
David Sans serves as EF Hutton advisor at Anixa Biosciences, a biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company’s vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer, as well as a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer.
David Sans - Philantrophy
Cancer Moonshot
David Sans serves in the advisory committee of the Cancer Moonshot program, initiative led by President Biden and the First Lady aimed to inspire and support the next generation of world-class and diverse scientists and health innovators focused on breakthroughs that will make a difference for patients and drive progress.
Cancer touches every American in some way, and is still the second leading cause of death in America despite the progress we’ve made in recent decades. By bringing together the federal government, health care providers, researchers, patients, caregivers, advocates, and the public and private sectors, the Cancer Moonshot is dramatically accelerating progress against cancer.
The Cancer Moonshot is mobilizing efforts toward achieving two clear goals that the President and First Lady set: To prevent more than 4 million cancer deaths by 2047 and to improve the experience of people who are touched by cancer.
